{"nct_id":"NCT04976634","title":"Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2021-08-18","start_date_type":"ACTUAL","primary_completion_date":"2027-03-22","primary_completion_date_type":"ESTIMATED","completion_date":"2027-03-22","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}